Long-term efficacy and safety of luspatercept for the treatment of anaemia in patients with transfusion-dependent β-thalassaemia (BELIEVE): final results from a phase 3 randomised trialMaria Domenica Cappellini, Alì Taher, Lee-Ping Chew et al.|The Lancet Haematology|2025Cited by 17
Effect of Luspatercept in β-Thalassemia Patients with β0/β0 Genotype: A Subgroup Analysis of the BELIEVE StudySujit Sheth, Maria Domenica Cappellini, Olivier Hermine et al.|Blood|2022Cited by 8
S270: LONGER-TERM ANALYSIS OF EFFICACY OF LUSPATERCEPT VERSUS PLACEBO IN PATIENTS WITH TRANSFUSION-DEPENDENT BETA-THALASSEMIA ENROLLED IN THE BELIEVE STUDYMaria Domenica Cappellini, Vip Viprakasit, Alì Taher et al.|HemaSphere|2022Cited by 6
Efficacy and Safety of Luspatercept in Patients Enrolled in the BELIEVE Trial: Data from the Phase 3b Long-Term Rollover StudyMaria Domenica Cappellini, Sujit Sheth, Alì Taher et al.|Blood|2023Cited by 1